DSP Healthcare Fund - Direct Plan - Growth

  • Scheme Category:  
  • Equity Scheme >  
NAV: ₹ 49.7950 ↓ -0.41%
[as on 1 October, 2026]

NAV chart

SMA (Simple Moving Average)

  • 50 SMA
  • 100 SMA
  • 200 SMA
  • 400 SMA

Returns

CAGR returns till date

CAGR returns of DSP Healthcare Fund - Direct Plan - Growth and its peers as on 1 October, 2026
NameYTD1D1W1M3M1Y3Y5Y7Y10Y
DSP Healthcare Fund - Direct Plan - Growth 14.38% -0.41% -3.06% -3.45% 3.21% 15.61% 20.7% 15.23% 25.89%-
Nippon India Banking & Financial Services Fund - Direct Plan Growth Plan - Growth Option -7.69% -0.2% -2.36% -5.58% -6.86% -1.79% 10.2% 12.12% 13.77% 12.61%
Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option 10.34% -0.29% -2.87% -2.96% 0.79% 12.36% 17.62% 13.51% 23.05% 15.49%
Nippon India Power & Infra Fund - Direct Plan Growth Plan - Growth Option 5.09% -1.35% -3.26% -4.54% -5.29% 6.07% 16.98% 19.46% 22.25% 17.59%
DSP Banking & Financial Services Fund - Direct - Growth -1.5% -0.91% -2.39% -7.87% -6.3% 5.81%----
BANDHAN Infrastructure Fund-Direct Plan-Growth -1.7% -1.07% -1.76% -2.31% -6.49% -3.58% 14.42% 16.21% 20.37% 16.1%

Discrete returns (yearly)

Year2016201720182019202020212022202320242025
Returns--- 9.49% 81.33% 23.43% -6.08% 39.27% 40.77% -4.93%

Discrete returns (monthly)

MonthDec 2025Jan 2026Feb 2026Mar 2026Apr 2026May 2026Jun 2026Jul 2026Aug 2026Sep 2026
Returns -1.09% -5.49% 1.5% -5.03% 7.3% 4.17% 6.5% 2.25% 4.79% -3.05%

Returns from spefic dates

DescriptionCAGR returns from 18 Oct 2021 (Nifty 50 2021 high)CAGR returns from 26 Sep 2024 (Nifty 50 2024 high)
Returns 15.4% 5.91%

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
96.14% 0.00% (Arbitrage: 0.00%) 0.00% 0.00% 3.86%

Equity

NameSymbol / ISINSectorWeight %Other links
IPCA Laboratories LimitedIPCALAB (INE571A01038)Pharmaceuticals & Biotechnology8.74%
Sun Pharmaceutical Industries LimitedSUNPHARMA (INE044A01036)Pharmaceuticals & Biotechnology7.95%
Sai Life Sciences LimitedSAILIFE (INE570L01029)Pharmaceuticals & Biotechnology7.45%
Cipla LimitedCIPLA (INE059A01026)Pharmaceuticals & Biotechnology7.35%
Apollo Hospitals Enterprise LimitedAPOLLOHOSP (INE437A01024)Healthcare Services6.47%
Gland Pharma LimitedGLAND (INE068V01023)Pharmaceuticals & Biotechnology5.98%
Divi's Laboratories LimitedDIVISLAB (INE361B01024)Pharmaceuticals & Biotechnology4.15%
Alkem Laboratories LimitedALKEM (INE540L01014)Pharmaceuticals & Biotechnology4.08%
Cohance Lifesciences LimitedCOHANCE (INE03QK01018)Pharmaceuticals & Biotechnology3.81%
Manipal Health Enterprises Limited (INE459N01021)Healthcare Services3.70%
Pfizer LimitedPFIZER (INE182A01018)Pharmaceuticals & Biotechnology3.22%
Alembic Pharmaceuticals LimitedAPLLTD (INE901L01018)Pharmaceuticals & Biotechnology3.14%
Kovai Medical Center And Hospital LimitedKOVAI (INE177F01017)Healthcare Services2.80%
Concord Biotech LimitedCONCORDBIO (INE338H01029)Pharmaceuticals & Biotechnology2.77%
Vijaya Diagnostic Centre LimitedVIJAYA (INE043W01024)Healthcare Services2.44%
Procter & Gamble Health LimitedPGHL (INE199A01012)Pharmaceuticals & Biotechnology2.40%
Thyrocare Technologies LimitedTHYROCARE (INE594H01019)Healthcare Services2.11%
Indoco Remedies LimitedINDOCO (INE873D01024)Pharmaceuticals & Biotechnology2.06%
Unichem Laboratories LimitedUNICHEMLAB (INE351A01035)Pharmaceuticals & Biotechnology1.64%
Syngene International LimitedSYNGENE (INE398R01022)Healthcare Services1.31%
Nephrocare Health Services LimitedNEPHROPLUS (INE428V01029)Healthcare Services1.13%
ICICI Lombard General Insurance Co LimitedICICIGI (INE765G01017)Insurance0.99%
Aarti Drugs LimitedAARTIDRUGS (INE767A01016)Pharmaceuticals & Biotechnology0.91%
Eris Lifesciences LimitedERIS (INE406M01024)Pharmaceuticals & Biotechnology0.76%
Jupiter Life Line Hospitals Limited (INE682M01020)Healthcare Services0.40%
Laxmi Dental LimitedLAXMIDENTL (INE0WO601020)Healthcare Equipment & Supplies0.14%
Globus Medical Inc (US3795772082)Healthcare Equipment & Supplies5.44%
Intuitive Surgical Inc (US46120E6023)Healthcare Equipment & Supplies1.76%
Abbott Laboratories (US0028241000)Pharmaceuticals & Biotechnology0.87%
Grail Inc (US3847471014)Healthcare Equipment & Supplies0.17%

Debt

NameIsinRatingWeight %Yield
Portfolio data is as on date 31 August, 2026

NAV history

DSP Healthcare Fund - Direct Plan - Growth - 30 days NAV (Net asset value) history

DateNAV% change
1 October, 202649.7950 -0.41%
30 September, 202650.0020 -2.07%
29 September, 202651.0610 0.59%
28 September, 202650.7640 -1.01%
25 September, 202651.2810 -0.16%
24 September, 202651.3650 -0.5%
23 September, 202651.6210 0.59%
22 September, 202651.3200 -0.66%
21 September, 202651.6630 0.69%
18 September, 202651.3110 1.1%
17 September, 202650.7530 1.07%
16 September, 202650.2160 0.31%
15 September, 202650.0620 -1.3%
11 September, 202650.7200 -0.24%
10 September, 202650.8420 -0.47%
9 September, 202651.0830 -0.23%
8 September, 202651.2020 0.05%
4 September, 202651.1740 -0.38%
3 September, 202651.3700 -0.26%
2 September, 202651.5050 -0.13%
1 September, 202651.5740 -0.23%
31 August, 202651.6930 0.32%
28 August, 202651.5260 -0.01%
27 August, 202651.5290 -0.03%
26 August, 202651.5470 0.64%
25 August, 202651.2190 0.51%
24 August, 202650.9610 -0.65%
21 August, 202651.2930 0.11%
20 August, 202651.2370 0.14%
19 August, 202651.1660

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of DSP Healthcare Fund - Direct Plan - Growth?
    The latest NAV of DSP Healthcare Fund - Direct Plan - Growth is 49.7950 as on 1 October, 2026.
  • What are YTD (year to date) returns of DSP Healthcare Fund - Direct Plan - Growth?
    The YTD (year to date) returns of DSP Healthcare Fund - Direct Plan - Growth are 14.38% as on 1 October, 2026.
  • What are 1 year returns of DSP Healthcare Fund - Direct Plan - Growth?
    The 1 year returns of DSP Healthcare Fund - Direct Plan - Growth are 15.61% as on 1 October, 2026.
  • What are 3 year CAGR returns of DSP Healthcare Fund - Direct Plan - Growth?
    The 3 year annualized returns (CAGR) of DSP Healthcare Fund - Direct Plan - Growth are 20.7% as on 1 October, 2026.
  • What are 5 year CAGR returns of DSP Healthcare Fund - Direct Plan - Growth?
    The 5 year annualized returns (CAGR) of DSP Healthcare Fund - Direct Plan - Growth are 15.23% as on 1 October, 2026.
  • What are top 10 holdings of DSP Healthcare Fund - Direct Plan - Growth?
    Top 10 holdings of DSP Healthcare Fund - Direct Plan - Growth are:
    • IPCA Laboratories Limited
    • Sun Pharmaceutical Industries Limited
    • Sai Life Sciences Limited
    • Cipla Limited
    • Apollo Hospitals Enterprise Limited
    • Gland Pharma Limited
    • Divi's Laboratories Limited
    • Alkem Laboratories Limited
    • Cohance Lifesciences Limited
    • Manipal Health Enterprises Limited
    • Pfizer Limited
  • What is LTCG (Long term capital gain) and STCG (Short term capital gain) tax for DSP Healthcare Fund - Direct Plan - Growth?
    DSP Healthcare Fund - Direct Plan - Growth is equity oriented mutual fund. Various capital gain taxes are applicable as below (Effective for redemption after July 23, 2024 and from FY 2024-25)
    Holding periodTax rate
    Less than 1 year (STCG)20%
    More than 1 year (LTCG)Tax free upto Rs. 1.25 lakhs. 12.5% on rest amount.